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Myosin Va (MyoVa) is an actin-based molecular motor that plays key roles in the final stages
of secretory pathways, including neurotransmitter release. Several studies have addressed
how MyoVa coordinates the trafficking of secretory vesicles, but why this molecular motor is
found in exosomes is still unclear. In this work, using a yeast two-hybrid screening system,
we identified the direct interaction between the globular tail domain (GTD) of MyoVa and four
protein components of exosomes: the WD repeat-containing protein 48 (WDR48), the cold
shock domain-containing protein E1 (CSDE1), the tandem C2 domain-containing protein
1 (TC2N), and the enzyme spermine synthase (SMS). The interaction between the GTD of
MyoVa and SMS was further validated in vitro and displayed a Kd in the low micromolar range
(3.5 +− 0.5 μM). SMS localized together with MyoVa in cytoplasmic vesicles of breast cancer
MCF-7 and neuroblastoma SH-SY5Y cell lines, known to produce exosomes. Moreover,
MYO5A knockdown decreased the expression of SMS gene and rendered the distribution
of SMS protein diffuse, supporting a role for MyoVa in SMS expression and targeting.
Introduction
Class V myosins are processive motors that transport or tether vesicles, organelles, and macromolecules
to actin filaments, and play key roles in synaptic transmission, hormone secretion, and plasma membrane
homeostasis [1–6]. They can be divided into four major structural domains with specific functions: the
motor domain, which contains the actin-binding site and displays ATPase activity, the lever arm that pro-
vides a large powerstroke to occur after ATP hydrolysis, the rod region, responsible for dimerization, and
the globular tail domain (GTD), a protein-binding module that allows multiple roles for these molecu-
lar motors [3,4,7–10]. In humans, three paralogous genes encode for class V myosins: MYO5A, MYO5B,
and MYO5C. Defects in the MYO5A gene are related to the Griscelli syndrome type 1 (also known as Ele-
jalde syndrome) [11,12], which is characterized by partial albinism and severe neurological disorders. The
molecular mechanism behind the partial albinism involves defects on a tripartite complex between myosin
Va (MyoVa), melanophilin, and Rab27a for melanosomes transport [13,14]. However, for the pleiotropic
effects of MYO5A mutation in neurodevelopment, the mechanisms are still poorly understood [15].
In neuronal cells, MyoVa has been associated with organelle transport, mRNA trafficking and exocy-
tosis of secretory vesicles [1,2]. Particularly in exocytosis, MyoVa seems to play several roles, including
the capture and transport of the secretory granules in the F-actin-rich cortex, the remodeling of their
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membranes required for maturation, and their controlled release [16]. To date, most of the studies about MyoVa
have focused on understanding how it regulates the trafficking of secretory vesicles. However, none of them have
investigated whether MyoVa could also influence the internal composition of such vesicles, even though MyoVa is
recurrently found in extracellular vesicles called exosomes [17].
In this work, to investigate whether MyoVa directly interacts with soluble protein components of exosomes, we per-
formed a two-hybrid screening using the GTD of MyoVa as bait and a universal human-normalized library as prey.
As envisaged, we identified the interaction of MyoVa-GTD with four proteins that compose exosomes, including the
enzyme spermine synthase (SMS), which plays key roles in neurodevelopment and brain function. SMS interacts with
MyoVa-GTD in vitro, with a Kd in the low micromolar range, and localizes together with MyoVa in vesicles at the
cytoplasm of two exosome-producer cell types. MYO5A gene silencing led to a diffuse distribution of SMS, indicating
a novel role of MyoVa in the targeting of this enzyme to secretory vesicles. Moreover, either MYO5A knockdown or
knockout decreased SMS gene expression, supporting that MyoVa may influence the synthesis or stability of SMS
mRNA. As SMS produces the neuromodulator spermine, which is stored in secretory vesicles and released via exo-
cytosis, our findings might have implications not only in the targeting of spermine synthase to exosomes but also in
the molecular mechanisms underlying the secretion of spermine.
Materials and methods
Yeast two-hybrid screening
The yeast two-hybrid screening was performed using the Matchmaker® Gold yeast two-hybrid system (Takara Bio –
Clontech) according to the manufacturer’s instructions. All reagents used in this screen was purchased from Takara
Bio – Clontech, unless stated otherwise. The MyoVa-GTD-S1651E/S1652E [9] coding sequence (residues 1448–1855;
NP 000250.3) was subcloned into the EcoRI and SalI sites of pGBKT7 (pGBKT7-EE construct), and was used to
transform Saccharomyces cerevisiae Y2H Gold® strain. This phosphomimetic (EE) construct was the bait because
our original aim was to identify phospho-specific interactions. The pGADT7-Prey plasmid of clones positive for the
activation of all reporter genes of the system (HIS3, ADE2, AUR1-C, and MEL1) were extracted using the Easy Yeast
Plasmid Isolation Kit. The purified vectors were transformed into Escherichia coli DH5α competent cells, extracted
with the QIAprep Spin Miniprep Kit (Qiagen), submitted to DNA sequencing, and compared with non-redundant
sequence databases using BLASTn and BLASTx [18].
Yeast two-hybrid pairwise validation
To validate the positive hits identified in the yeast two-hybrid screen and to test whether the interactions were depen-
dent of the phosphomimetic mutation, S. cerevisiae Y2H Gold® cells were co-transformed with a pair of pGBKT7
and pGADT7 vectors (Supplementary Table S1), and grown at 30◦C for 4 days on QDO/X/A-agar plates – a synthetic
defined agar medium without tryptophan, leucine, histidine and adenine, and supplemented with 200 ng/ml aureoba-
sidin A and 40 μg/ml 5-bromo-4-chloro-3-indolyl alpha-D-galactopyranoside (Takara Bio – Clontech). To remove
potential false-positive results, we tested the activation of all reporter genes in Y2H Gold® cells co-transformed with
pGADT7-Prey and empty pGBKT7 vectors (negative controls).
Bioinformatics validation
The nucleotide sequences of preys validated in the previous step were subjected to bioinformatics analyses to filter
out possible false positives still present. Initially, the sequences were analyzed using BLASTn [18] to remove those hits
containing 5′ or 3′ UTR in frame with the GAL4 AD sequence, which would generate artificial fusion proteins. For
constructs containing truncated open reading frames (ORF), only those hits containing at least one intact domain
were considered as true positives, according to protein sequence analyses using the SMART server [19].
Molecular cloning
The full-length SMS ORF (NM 004595.4, 253-1353 pb) was amplified from a human cDNA library by PCR using
the primers shown in Supplementary Table S2. The PCR product was purified with QIAquick PCR Purification Kit
(Qiagen), digested using NdeI and XhoI restriction enzymes and inserted into the NdeI/XhoI sites of pET28a tobacco
etch virus (TEV) vector [9] using T4 DNA Ligase (Promega). Positive clones were confirmed by DNA sequencing.
Microscale thermophoresis
To perform the microscale thermophoresis (MST) experiment, the wild-type MyoVa-GTD [9] and SMS constructs
(both in pET28a-TEV vector) were produced in BL21(DE3)SlyD strain containing the plasmid pRARE2, in LB
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medium [20] at 25◦C for 4 h, and 20◦C for 16 h, respectively. The cell lysis was performed by sonication (Vibra-cells,
Sonics) with lysis buffer (50 mM HEPES, 500 mM NaCl, 5% (v/v) glycerol, 20 mM imidazole, pH 7.4) supplemented
with 0.1 mg/ml lysozyme, and SIGMAFAST™ Protease Inhibitor Tablets (Sigma-Aldrich). All proteins were purified
by two chromatographic steps, using a HiTrap Chelating column (GE Healthcare), with an imidazole gradient for
protein elution, and a HiLoad Superdex 200 (or 75) 16/60 column (GE Healthcare). The size-exclusion chromatog-
raphy (SEC) was carried out in SEC buffer (20 mM HEPES, 150 mM NaCl, 5% (v/v) glycerol, pH 7.4). MyoVa-GTD
purified by affinity chromatography was treated with a His-tagged TEV protease [21] (4◦C, 20 h) for the cleavage of
the 6xHis-tag before the purification in a HiLoad Superdex 200 16/60 column (GE Healthcare) pre-equilibrated with
SEC buffer.
The MST experiment was performed using a Monolith™ NT.115 (NanoTemper Technologies) device, with a
LED power of 40%, and a MST power of 60%. SMS was labeled with the His-Tag Labeling Kit RED-tris-NTA
(NanoTemper Technologies), following the manufacturer’s labeling protocol, and loaded into Monolith™ NT.115
MST premium-coated capillaries (NanoTemper Technologies). All assays were performed in triplicate using 50 nM
His-tagged-labeled-SMS and a serial dilution of MyoVa-GTD to the maximum possible concentration in SEC buffer.
The differences between the cold and hot states of each of the 16 MST profiles were used to determine the change
in fluorescence intensities for each profile using the following equation: Fnorm = Fhot/Fcold · 1000, where F is the
fluorescence measured in each state. The data were processed using the NTAffinity Analysis software (NanoTemper
Technologies) and the mean of Fnorm triplicates plotted against ligand concentration were fitted with the Hill equation
(Fnorm = [L]n/Kd + [L]n , where [L] = ligand concentration, n = Hill coefficient, and Kd = dissociation constant)
using the Origin 8.0 software to estimate the Kd.
Immunocytochemistry and gene silencing assays
Immunocytochemistry assays were performed on human neuroblastoma (SH-SY5Y) and human mammary adeno-
carcinoma (MCF-7) cell lines cultured in Dulbecco’s modified Eagle’s medium (DMEM) with high glucose (GIBCO -
Thermo Fisher Scientific: 12800-017) supplemented with 10% (v/v) fetal bovine serum (FBS) 100 units/ml penicillin
and 100μg/ml of streptomycin and kept in a humid atmosphere containing 5% (v/v) CO2 at 37◦C. The Stealth RNAi™
siRNAs targeting MYO5A were purchased from Invitrogen – Thermo Fisher Scientific and are shown in Supplemen-
tary Table S3. A scramble sequence Stealth RNAi™ siRNA Negative Control High GC Duplex (Invitrogen – Thermo
Fisher Scientific) was used as a control.
MCF-7 cells were transfected using DharmaFECT 1 Transfection Reagent (GE Healthcare) according to the man-
ufacturer’s instructions. Cells were fixed with 2% (v/v) paraformaldehyde pH 7.4 for 20 min, and then permeabilized
with 0.3% (v/v) Triton X-100, blocked with 100 mM glycine, and then 3% (m/v) BSA (adapted from Assis et al. [7]).
The following antibodies were used: 1 μg/ml rabbit anti-SMS (Sigma-Aldrich: HPA029852); 2 μg/ml rat polyclonal
affinity-purified anti-MyoVa Medial Tail (in house, manuscript in preparation). Secondary antibodies used were 2
μg/ml Alexa Fluor® goat anti-rat 488 (Abcam: ab150157), 2 μg/ml Alexa Fluor® donkey anti-rabbit 594 (Molecu-
lar Probes: A21207) IgG. The slides were mounted on ProLong® Diamond Antifade Mountant medium with DAPI
(Thermo Fisher Scientific: P36962) and the images were collected on Zeiss LSM780 Axio Observer multifotons in-
verted confocal microscope, with a 63× objective. The Icy BioImage open source software from the Pasteur Institute
(http://icy.bioimageanalysis.org/) was used for image processing and calculation of the Pearson’s coefficients with the
colocalization studio plugin [22]. All the compared images were acquired with the same parameters. The raw files
were used for all quantifications.
RNA isolation and quantitative PCR
Total RNA was extracted from the cells samples according to standard TRIzol protocol (Invitrogen – Thermo Fisher
Scientific). Total RNA (1 μg) was reverse transcribed to cDNA using High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems – Thermo Fisher Scientific) according to a standard manufacturer’s protocol followed by am-
plification on the ABI 7500 Real-Time PCR System (Applied Biosystems – Thermo Fisher Scientific), using primers
from the Supplementary Table S4. Samples of SH-SY5Y cells (control and differentiated) were prepared as described
below. All quantitative PCR (qPCR) analyses were performed in triplicate. The expression of endogenous control
(GAPDH) was used for the normalization of RNA input.
Gene expression levels were calculated by relative quantitation using the ABI 7500 Real-Time PCR SDS 1.2 software
(Applied Biosystems – Thermo Fisher Scientific) and the fold expression changes were determined by 2−CT method
[23]. The data are presented as the fold change of mRNA expression in cells treated with siRNA relative to cells treated
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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with siControl after normalization to an endogenous control (GAPDH or TBP). The qPCR data were described as
mean +− standard deviation and analyzed using the Student’s t test, with P≤0.01 considered statistically significant.
Neuronal differentiation
SH-SY5Y cells were cultivated in DMEM high glucose (GIBCO – Thermo Fisher Scientific: 12800-017), supple-
mented with 10% (v/v) FBS (GIBCO – Thermo Fisher Scientific) and 100 units/ml penicillin and 100 μg/ml of
streptomycin (GIBCO – Thermo Fisher Scientific: 15140122) and kept in a humid atmosphere containing 5% (v/v)
CO2 at 37◦C. Cellular differentiation was induced as described by Encinas and coworkers [24] with some modi-
fications. Briefly, 2.5 × 104 cells/cm2 were plated on DMEM high glucose medium supplemented with 10% (v/v)
FBS and 1% penicillin/streptomycin solution, in culture plates or on 13 mm2 glass coverslips previously treated with
0.1 mg/ml poly-D-lysin (Sigma-Aldrich). The next day, the medium was removed and replaced with medium II
(DMEM high glucose medium containing 1% (v/v) FBS, 1% penicillin/streptomycin solution and 10 μM retinoic
acid [Abcam: ab120728]). After 3 days of growth, medium was replaced with fresh medium II supplemented with 50
ng/ml brain-derived neurotrophic factor (BDNF; Sigma-Aldrich: SRP3014) and cells were grown for further 4 days.
RNA extraction and qPCR assays were performed as described above.
Culture of FO and RO fibroblasts
FO cells are human fibroblasts isolated from skin fragments of a patient carrying a mutation in the MYO5A gene,
which renders these cells null for MyoVa protein (Griscelli Syndrome type I/Elejalde syndrome). RO cells are normal
human fibroblasts age-paired with FO, also isolated in the same laboratory, and used as control. The cells were cultured
in DMEM high glucose (GIBCO – Thermo Fisher Scientific: 12800-017) supplemented with 10% (v/v) FBS (GIBCO
– Thermo Fisher Scientific), at 37◦C, 5% (v/v) CO2. Total RNA was extracted using standard TRIzol protocol and used
for cDNA synthesis and qPCR, as described above. All methods presented here were performed in accordance with
the relevant guidelines and regulations approved by Faculty of Medicine of Ribeirão Preto, University of São Paulo and
in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki). Primary cultures
were established with the informed consent of the patients and with the approval of the Research Ethics Committee
of the Faculty of Medicine of Ribeirão Preto.
Results
Using MyoVa-GTD as bait, we obtained 54 clones in a yeast two-hybrid screen of a human-normalized cDNA library.
These clones represented 35 different genes, according to DNA sequence analyses of the prey plasmids. To further
validate these results, we performed a pairwise two-hybrid assay resulting in 21 positive clones. However, nine of them
were from noncoding regions, such as 5′ and 3′ UTRs of mRNA, and three encoded zinc finger proteins or heat shock
proteins, which are recurrent false positives in yeast two-hybrid assays [25] (Table 1). After the exclusion of truncated
single-domain proteins (probably misfolded), four clones remained as potential binding partners of MyoVa-GTD:
SMS, WDR48, CSDE1, and TC2N (Figure 1A,B). Interestingly, these four proteins are known components of exo-
somes (Table 2). Further, we evaluated whether these interactions could be regulated by the MyoVa-GTD phospho-
rylation at Ser1652. However, the four proteins interacted with both the GTD-EE (S1651E/S1652E) and GTD-AA
(S1651A/S1652A) constructs in a pairwise two-hybrid assay, indicating that their binding to GTD is independent of
the phosphorylation under the tested conditions (Figure 1A). The Ala mutant was used to mimic the nonphospho-
rylated state of MyoVa-GTD and preserves the structure and dynamic behavior of the wild-type construct produced
in E. coli [9].
After analyzing the functional data available for SMS, WDR48, CSDE1, and TC2N in the literature, we decided to
further characterize the interaction between MyoVa-GTD and SMS due to the key role of this enzyme in neurode-
velopment [26,27]. For in vitro affinity assays, MyoVa-GTD and SMS proteins were expressed and purified to homo-
geneity (Supplementary Figures S1 and S2), the His-tag of MyoVa-GTD was removed, and the purified SMS protein
was labeled with the RED-tris-NTA dye (Supplementary Figure S3). According to MST experiments, MyoVa-GTD
and SMS formed a complex in vitro with a dissociation constant of 3.5 +− 0.5 μM (Figure 1C), supporting SMS as a
novel MyoVa-binding partner.
In breast cancer (MCF-7) and neuroblastoma (SH-SY5Y) cell lines, SMS localized together with a subset of
MyoVa-labeled vesicles at the cytoplasm (Figure 2). We also noticed that MYO5A knockdown induced a more diffuse
distribution of SMS, in contrast to the fewer, but sharper puncta observed at the control (Figure 3A), indicating that
MyoVa may play a role in the targeting of SMS to vesicles.
4 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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68 NM 001165979.2 7561–7955 635–7495 3’ UTR
78 NG 008805.2 8745–9860 396–9011 2783–2871 Fibrillin 1 (2871) Unfolded region
88 NR 033192.1 198–1074 45-774 HSP – Recurrent
false positive
104 BC038384.1 894–1513 121–1095 258–324 Y box binding
protein 1 (324)
CSP (60–128) Unfolded region
106 NM 138773.2 3372–4495 127–1383 3’ UTR
108 AL139288.15 138495–139600 Chromosomal
untranscribed regions







142 NM 152332.5 1045–2180 214–1686 277–490 Tandem C2
domains nuclear
protein (490)




151 XM 006716253.2 4257–5384 115–972 3’ UTR











Potential MyoVa-binding partners are highlighted in bold.
*The final pb identified in our sequencing, not the final pb in the prey.
Table 2 Proteins that interacted with MyoVa-GTD in the yeast two-hybrid system are components of exosomes
and/or secretory vesicles
Protein Tissue/cell type [vesicle type] Database [ID] Ref.
SMS Breast cancer cells [exosomes] Vesiclepedia [VP 20603] [44]
WDR48 Breast cancer cells [exosomes]; melanoma cells [extracellular vesicles]; Vesiclepedia [VP 67561] [44]
Mouse embryonic fibroblasts [extracellular vesicles]
TC2N Breast milk [exosomes]; colorectal cancer cells [microvesicles]; Vesiclepedia [VP 123036] [44]
Mesenchymal stem cells [microvesicles]; urine [exosomes]
CSDE1 Mast cells [exosomes] Exocarta [ExoCarta 229663] [17]
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 1. Yeast two-hybrid and in vitro assays reveal SMS as a novel binding partner of MyoVa-GTD
(A) Pairwise two-hybrid assays showing the activation of four reporter genes (QDO/X/A selective medium) in yeast cells co-trans-
formed with pGADT7-prey (or empty pGADT7 as a control) plasmids and pGBKT7-GTD constructs (EE = phosphomimetic and
AA = non-phosphorylated) showing that the identified interactions are not specific to the phosphomimetic mutant. The first line
represents the negative control assays, where each clone was tested against the empty pGBKT7 vector (DBD). (B) Schematic
representation of the domain architecture of the new-found partners. The red bar indicates the prey boundaries found in the yeast
two-hybrid screening: SMS90–366 = catalytic domain of SMS (NCBI accession number: EAW98985); WDR48451–677 = DUF3337
domain of the WDR48 (NCBI accession number EAW64548); TC2N277–490 = contains the second C2 domain of the tandem C2 do-
mains nuclear protein (TC2N; NCBI accession number: EAW81464); CSDE1692–798 = contains the SUZ-C domain of the cold shock
domain-containing protein E1, isoform 4 (CSDE1; NCBI accession number: NP 001007554). Figures were made using SMART [19]
and IBS [41]. (C) MST assays showing that MyoVa-GTD binds to SMS with a Kd in the low micromolar range. Fnorm = normalized
fluorescence. Data are presented as mean +− SD (error bars) from triplicates.
6 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 2. MyoVa and SMS localize together in discrete puncta at the cytoplasm
Immunocytochemistry showing the colocalization of MyoVa (green; anti-MyoVa-Medial tail) and SMS (red) labeling in MCF-7 (A-C)
and SH-SY5Y (D-F) cell lines. The overlap of the fluorescent signals is shown in yellow (overlay). (B,E) Linescan analysis of two
representative colocalization sites. (C, F) Pearson’s correlation coefficients support the partial colocalization of MyoVa (green)
and SMS (red) labeling. The correlation is based on the average of 16 and 18 independent cells, for MCF-7 and SH-SY5Y cells,
respectively, with standard deviations shown. The correlation between MyoVa (rotated 180◦) and SMS channels was used as
negative control (random colocalization). Nucleus were stained with DAPI (Blue). Scale bar: 10 μm (field), 1 μm (zoom). **** P≤0.001
from two-tailed Wilcoxon’s non-parametric rank test in C (because one of the populations were not normally distributed) and
two-tailed paired t test in F).
According to qPCR analyses, the mRNA expression levels of SMS decreased upon MYO5A-silencing (Figure
3B,C), which correlated with a slight decrease in SMS protein content assessed by Western blot (Supplementary Fig-
ure S4). To investigate a possible correlation between depletion of MyoVa protein and SMS transcription, we also
evaluated the expression of SMS in MYO5A-null primary fibroblasts isolated from patients with Griscelli Syndrome
Type 1/Elejalde syndrome. As expected, the SMS expression was lower in cells lacking functional MyoVa compared
with normal primary fibroblasts, indicating a role for MyoVa in the synthesis or stability of SMS mRNA (Figure 3D).
In contrast, when the expression of MYO5A was stimulated upon neuron differentiation, the expression level of SMS
also increased, further supporting a correlation between the expression of these two genes (Figure 3E–G).
Discussion
In this work, we reveal the direct interaction between MyoVa-GTD and four components of exosomes – WDR48,
CSDE1, TC2N, and SMS – using a highly stringent yeast two-hybrid system. Furthermore, we validate the interaction
between MyoVa-GTD and the enzyme SMS in vitro, and provide primary evidence about a new role for MyoVa in
the expression and targeting of SMS into secretory vesicles.
MyoVa-GTD and SMS form complexes in vitro with a dissociation constant in the low micromolar range (Kd =
3.5 +− 0.5 μM), which is typical of transient complexes and is similar to the affinity of MyoVa-GTD to other binding
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 3. MYO5A knockdown affects SMS distribution and expression in MCF-7 cells
(A) Immunocytochemistry showing that the puncta distribution of SMS (siControl) became diffuse in cells treated with siMYO5A.
Nucleus were stained with DAPI (Blue). Scale bar: 10 μm. (B) qPCR showing that the siMYO5A treatment was effective to reduce
MYO5A mRNA expression. (C) The qPCR showing the relative mRNA expression of SMS in cells treated with siControl or siMYO5A
and in (D) MYO5A-null fibroblasts (FO−/−) and the normal control (RO). The qPCR analysis of expression of the marker for neuronal
differentiation NeuN (E), MYO5A (F), and SMS (G) in normal and differentiated neuronal SH-SY5Y cells. * P≤0.05; ** P≤0.01; ***
P≤0.001, **** P≤0.0001. Paired t test, two-tailed.
partners, such as the C2 domains of RPGRIP1L (3–9 μM, also determined by MST but using a covalent probe) [7].
The protein SMS has been found in the cytosol, in nuclear bodies and in exosomes [28–30]. This enzyme converts
spermidine into spermine (EC 2.5.1.22) [31–33], a polyamine that acts as second messenger in neurotransmission,
targeting receptors in postsynaptic membranes [34–36]. The vesicular storage of spermine and spermidine involves
an active transporter from the SLC18 family, but the mechanisms coupling spermine synthesis to secretion are still
elusive [37]. In this context, and based on our results showing the physical interaction between MyoVa-GTD and
SMS, the colocalization of SMS and MyoVa in a subset of cytoplasmic vesicles and the more diffuse distribution of
SMS protein upon MYO5A gene silencing, it is tempting to hypothesize that the actin-based motor MyoVa targets
the enzyme that produces spermine to secretory vesicles for spermine secretion via exocytosis [37,38], and/or SMS
8 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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release via exosomes [28,29]. Moreover, whether and how the interaction between MyoVa and SMS influence the
spermine synthase activity should be further evaluated in future studies.
Besides our RNAi studies show lower levels of SMS mRNA upon MYO5A silencing, other evidences support a
correlation between MYO5A and SMS expression. In MYO5A-null fibroblasts, SMS transcripts are less abundant
than in normal cells, indicating that functional MyoVa is required for the usual expression of SMS gene. Moreover,
MYO5A and SMS are up-regulated in differentiated neurons and the proteins they encode are less abundant in human
brains with Huntington’s disease, a progressive neurodegenerative disorder [39]. Phenotypic traits further support a
correlation between MyoVa and SMS, since patients harboring loss-of-function mutations in SMS or MYO5A genes
share some neurological symptoms, including intellectual disability, seizures, and hypotonia [12,27,40].
In summary, the new interaction between MyoVa and exosomes components, including the enzyme SMS, and the
co-occurrence of MyoVa and SMS in cytoplasmic vesicles bring new perspectives about the roles of this molecular
motor in exocytic pathways, especially in the filling of exosomes and secretion of the neuromodulator spermine.
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